Shanghai RAAS Blood Products (002252.SZ) - EPS (earnings per share)

EPS in 2025 (TTM): S$0.07504

According to Shanghai RAAS Blood Products's latest financial reports the company's current EPS (TTM) is S$0.07237. In 2024 the company made an earnings per share (EPS) of S$0.05858 an increase over its 2023 EPS that were of S$0.04949.

EPS history for Shanghai RAAS Blood Products from 2005 to 2025

Annual EPS

Year	EPS	Change
2025 (TTM)	S$0.07504	28.09%
2024	S$0.05858	18.38%
2023	S$0.04949	-5.91%
2022	S$0.05260	36.15%
2021	S$0.03863	-7.39%
2020	S$0.04171	87.44%
2019	S$0.02225	-138.11%
2018	S-$0.05840	-272.5%
2017	S$0.03385	-45.02%
2016	S$0.06157	5.85%
2015	S$0.05817	127.47%
2014	S$0.02557	48.29%
2013	S$0.01724	29.9%
2012	S$0.01328	13.1%
2011	S$0.01174	14.18%
2010	S$0.01028	40.49%
2009	S$0.007317	13.05%
2008	S$0.006473	18.08%
2007	S$0.005482	-37.8%
2006	S$0.008814	2.48%
2005	S$0.008600

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

EPS for Shanghai RAAS Blood Products (002252.SZ)